MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

MOLECULAR PARTNERS AG

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026

$3.66+0.10 (+2.81%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

CHF 0FY2025

Parsed from the XBRL in Molecular Partners's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MOLN.

Revenue growth-100.0% · median -30.0%

Advertisement
300 × 250